Research analysts at StockNews.com assumed coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) in a report released on Tuesday. The firm set a “buy” rating on the biopharmaceutical company’s stock. Separately, TheStreet lowered Horizon Therapeutics Public from a “b-” rating to a “c+” rating in a research report on Monday, May 8th. […]
Deutsche Bank AG grew its stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 6.3% during the 4th quarter, HoldingsChannel reports. The firm owned 2,061,143 shares of the biopharmaceutical company’s stock after buying an additional 122,268 shares during the quarter. Deutsche Bank AG’s holdings in Horizon Therapeutics Public were worth $234,558,000 as of […]
Gabelli Funds LLC purchased a new position in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 222,000 shares of the biopharmaceutical company’s stock, valued at approximately $25,264,000. Gabelli Funds LLC owned about 0.10% of Horizon […]
Northeast Financial Consultants Inc purchased a new stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,068 shares of the biopharmaceutical company’s stock, valued at approximately $235,000. Other institutional investors […]
Utah Retirement Systems lessened its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) by 2.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 39,300 shares of the biopharmaceutical company’s stock after selling 900 shares during the quarter. Utah Retirement Systems’ holdings in […]